Anti-diabetic combination therapy with pioglitazone or glimepiride added to metformin on the AGE-RAGE axis: a randomized prospective study.

Ragazzi, Eugenio; Burlina, Silvia; Cosma, Chiara; Chilelli, Nino Cristiano; Lapolla, Annunziata; Sartore, Giovanni

Ragazzi, Eugenio; Burlina, Silvia; Cosma, Chiara; Chilelli, Nino Cristiano; Lapolla, Annunziata; Sartore, Giovanni.

Afiliación

Ragazzi E; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
Burlina S; Department of Medicine - DIMED, University of Padova, Padova, Italy.
Cosma C; Department of Medicine - DIMED, University of Padova, Padova, Italy.
Chilelli NC; Department of Medicine - DIMED, University of Padova, Padova, Italy.
Lapolla A; Department of Medicine - DIMED, University of Padova, Padova, Italy.
Sartore G; Department of Medicine - DIMED, University of Padova, Padova, Italy.

Front Endocrinol (Lausanne) ; 14: 1163554, 2023.

Article en En | MEDLINE | ID: mdl-37635976

Asunto(s)

Diabetes Mellitus Tipo 2; Metformina; Humanos; Diabetes Mellitus Tipo 2/tratamiento farmacológico; Metformina/uso terapéutico; Pioglitazona; Estudios Prospectivos

Palabras clave

AGEs; advanced glycation end products; glimepiride; pioglitazone; s-RAGE; type 2 diabetes mellitus

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Metformina Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google